A Double-Blind, Randomized, Placebo-Controlled, Study To Assess Efficacy, Safety And Tolerability Of Crofelemer In Adult Patients With Acute Infectious Diarrhea.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Crofelemer (Primary)
- Indications Bacterial infections; Diarrhoea
- Focus Therapeutic Use
- 15 Feb 2011 Top-line results reported in a Napo Pharmaceuticals media release.
- 15 Feb 2011 Status changed from not yet recruiting to completed.
- 03 Feb 2010 Planned patient number (80) added, additional lead trial investigator identified as reported by Clinical Trials Registry - India record.